Surgical Science Sweden AB (publ) (OTCMKTS:SUSRF) Stock Price Down 21.8% – What’s Next?

Shares of Surgical Science Sweden AB (publ) (OTCMKTS:SUSRF) were down 21.8% on Thursday . The stock traded as low as $2.84 and last traded at $2.84. Approximately 1,200 shares changed hands during mid-day trading, a decline of 66% from the average daily volume of 3,524 shares. The stock had previously closed at $3.63.

Analysts Set New Price Targets

Separately, Pareto Securities lowered shares of Surgical Science Sweden AB (publ) to a “hold” rating in a research report on Wednesday, November 26th. One equities research analyst has rated the stock with a Hold rating, According to MarketBeat, Surgical Science Sweden AB (publ) has a consensus rating of “Hold”.

Surgical Science Sweden AB (publ) Stock Down 21.8%

The stock’s fifty day moving average price is $3.46 and its two-hundred day moving average price is $7.49.

Surgical Science Sweden AB (publ) Company Profile

Surgical Science Sweden AB (publ) develops and markets virtual reality–based medical simulation solutions designed to train healthcare professionals in minimally invasive surgical techniques. Headquartered in Gothenburg, Sweden, the company leverages advanced haptic feedback and three-dimensional graphics to create realistic, interactive scenarios for a range of surgical disciplines, including laparoscopy, endoscopy and arthroscopy. Its platform allows trainees to practice complex procedures in a risk-free environment, helping to improve precision and reduce the learning curve for both trainees and experienced practitioners adapting to new technologies.

The company’s product portfolio includes LapSim for basic and advanced laparoscopic skills, EndoSim for gastrointestinal endoscopy, ArthroSim for diagnostic and therapeutic arthroscopy, as well as modules for vascular and bronchial interventions.